Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Glomset

Sports Medicine Norman, OK Medical Doctor

NPI 1043400641 CMS profile 876714

3400 W Tecumseh Rd Ste 101, Norman, OK 73072

Open in the dashboard

General payments

$46,932

166 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Glomset of Norman, OK is reported in the CMS Open Payments database as having received $46,932 across 166 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,075 17
2024 General $18,662 28
2023 General $4,850 40
2022 General $3,639 24
2021 General $1,934 12
2020 General $2,168 15
2019 General $5,604 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Glomset
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to John Glomset were reported at $10,075. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year John Glomset Sports Medicine median Middle half National median
2019 $5,604 $1,176 $199–$4,249 $163
2020 $2,168 $708 $96–$2,890 $114
2021 $1,934 $1,213 $152–$3,994 $132
2022 $3,639 $1,230 $159–$3,998 $149
2023 $4,850 $584 $146–$2,836 $160
2024 $18,662 $628 $163–$3,168 $164
2025 $10,075 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $26,107 82 payments
  2. Smith+Nephew, Inc. $12,262 29 payments
  3. Pylant Medical $6,996 18 payments
  4. Arthrex, Inc. $624 13 payments
  5. Trice Medical, Inc. $262 2 payments
  6. Anika Therapeutics, Inc. $168 2 payments
  7. Nalu Medical, Inc. $153 1 payment
  8. Vericel Corporation $90 4 payments
  9. DePuy Synthes Sales Inc. $88 3 payments
  10. Orthofix Medical, Inc. $51 5 payments
  11. Other $131 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $16,125 6 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,663 3 payments
  3. Food and Beverage $7,622 121 payments
  4. Travel and Lodging $7,562 28 payments
  5. Education $6,961 8 payments
Products named General payments · program years 2019–2025
  1. TORNIER PERFORM REVERSED AUGMENTED GLENOID $8,699 3 payments
  2. Bone Anchors with Arthroscopic Delivery System $8,152 5 payments
  3. AEQUALIS PERFORM $7,879 9 payments
  4. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $6,294 26 payments
  5. AEQUALIS $4,500 2 payments
  6. AEQUALIS PERFORM REVERSED $2,783 6 payments
  7. TORNIER PERFORM REVERSED GLENOID $2,441 2 payments
  8. TORNIER PERFORM ANATOMIC AUGMENTED GLENOID $1,875 1 payment
  9. NA $1,875 1 payment
  10. Q-Fix $1,582 5 payments
  11. Other $12,557 111 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

471

Median for Orthopedic Surgery: 203

Drug cost

$6,491

Median for Orthopedic Surgery: $1,433

Branded share of claims

6.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 113 $4,114
Oxycodone Hcl Generic 129 $880
Tramadol Hcl Generic 78 $339
Ibuprofen Generic 21 $302
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 31 $243
Pregabalin Generic 33 $230
Methylprednisolone Generic 21 $195
Methocarbamol Generic 31 $145
Meloxicam Generic 14 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$141,632

Of which drugs: $6,969

Medicare patients

325

Average age 72

Services billed

1,499

182 women, 143 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 32%
Diabetes 30%
Depression 29%
Chronic kidney disease 22%
COPD 18%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 77 529 $360

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

166 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record